Chasing_Tendies

APLS ; target $40 pushed by 17% short interest

看多
NASDAQ:APLS   Apellis Pharmaceuticals, Inc.
Short interest of 17% can push this out of the wedge formed. Pharma stocks will make a comeback closer we get to vaccine hypes again once the tech bubble pops

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。